Search

everythinglearnresearchcommunity

for

Search:↓

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Antibody treatments show promise for hair loss but need more research.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Finasteride safely lowers DHT levels without affecting hormone levels, helping with conditions like enlarged prostate, acne, and hair loss.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

Prolactin affects when mice shed and grow hair.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

Melatonin implants and long daylight hours alter the timing of hormone release and hair growth in mouflon sheep.

Prolactin may be important for skin growth and immune function.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Prolactin affects when mice shed and grow hair.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

Selecting Angus cattle for earlier puberty lowers prolactin levels but doesn't affect hair growth.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Microneedle therapy combined with Hwangryeonhaedoktang solution improved hair growth in mice better than microneedle therapy alone.

A new gene, mrp4, is found in mice and may play a unique role in hair follicle development in tails and ears.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

Hormonal imbalances, not insulin resistance or dyslipidemia, may be more important in causing acne in women over 25.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Removing part of the vitamin D receptor stops vitamin D from working properly.

Certain mutations in a hair growth-related gene cause a type of genetic hair loss.